Literature DB >> 18751944

Evolution of living donor liver transplantation over 10 years: experience of a single center.

Susumu Eguchi1, Mitsuhisa Takatsuki, Masaaki Hidaka, Yoshitsugu Tajima, Takashi Kanematsu.   

Abstract

PURPOSE: To evaluate the changes in living donor liver transplantations (LDLTs) over the last 10 years, we analyzed our experience of performing LDLT in a single center.
METHODS: We performed 73 LDLTs over the 10 years between 1997 and 2007 in Nagasaki University Hospital, Japan.
RESULTS: Initially, from 1997 to 2003, LDLT was performed for pediatric patients; then, between 2004 and 2007, adult-to-adult LDLT was introduced, primarily for hepatocellular carcinoma (HCC) in liver cirrhosis. We also began performing LDLTs for adults with ABO-incompatible blood type combination in the latter period. As the number of adult-to-adult LDLTs increased, left-sided grafts became fi rst choice for these patients. Survival rates were 88.3%, 77.2%, 70.2% at 1, 3, and 5 years, respectively. There was a relatively low incidence of arterial complications, and although the incidence of biliary complications was high initially, it decreased with experience. Likewise, the operative time, blood loss, and hospital stay after LDLT also improved remarkably.
CONCLUSION: Over the last 10 years the indications for, and operative techniques used in LDLT have changed dramatically, even in a single center in Japan.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18751944     DOI: 10.1007/s00595-007-3729-8

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  20 in total

1.  Evolution of living donor liver transplantation in adults: a single center experience.

Authors:  T Kiuchi; Y Inomata; S Uemoto; K Asonuma; H Egawa; S Fujita; M Hayashi; K Uryuhara; K Tanaka
Journal:  Transpl Int       Date:  2000       Impact factor: 3.782

Review 2.  Hepatic artery reconstruction in living-donor liver transplantation: a review of its techniques and complications.

Authors:  Hideaki Uchiyama; Koji Hashimoto; Shoji Hiroshige; Noboru Harada; Yuji Soejima; Takashi Nishizaki; Mitsuo Shimada; Taketoshi Suehiro
Journal:  Surgery       Date:  2002-01       Impact factor: 3.982

3.  Hepatic arterial reconstruction in 95 adult right lobe living donor liver transplants: evolution of anastomotic technique.

Authors:  Amadeo Marcos; Mary Killackey; Mark S Orloff; Luis Mieles; Adel Bozorgzadeh; Henkie P Tan
Journal:  Liver Transpl       Date:  2003-06       Impact factor: 5.799

4.  Segmental (partial) liver transplantation from a living donor.

Authors:  N Nagasue; H Kohno; S Matsuo; A Yamanoi; M Uchida; Y Takemoto; T Nakamura
Journal:  Transplant Proc       Date:  1992-10       Impact factor: 1.066

5.  Portal venous reconstruction in a living liver donor with an anomalous hepatic arterial and portal venous anatomy.

Authors:  Shigeru Marubashi; Keizo Dono; Masato Sakon; Kunihito Gotoh; Hidenori Takahashi; Kazuhiko Hashimoto; Masaru Kubota; Shinji Yamamoto; Atsushi Miyamoto; Hiroaki Nagano; Shoji Nakamori; Koji Umeshita; Morito Monden
Journal:  J Gastrointest Surg       Date:  2005-03       Impact factor: 3.452

6.  Application of endovascular stapler in living-donor liver transplantation.

Authors:  Susumu Eguchi; Yujo Kawashita; Mitsuhisa Takatsuki; Takashi Kanematsu
Journal:  Am J Surg       Date:  2007-02       Impact factor: 2.565

7.  Which is the best timing of bile duct division in living liver donor surgery?

Authors:  Mitsuhisa Takatsuki; Susumu Eguchi; Takashi Kanematsu
Journal:  Liver Transpl       Date:  2007-08       Impact factor: 5.799

8.  A modified triangular venoplasty for reconstruction of middle hepatic vein tributaries in living donor liver transplantation.

Authors:  Susumu Eguchi; Mitsuhisa Takatsuki; Akihiko Soyama; Masaaki Hidaka; Hirotaka Tokai; Koji Hamasaki; Kensuke Miyazaki; Shungo Miyamoto; Yoshitsugu Tajima; Takashi Kanematsu
Journal:  Surgery       Date:  2007-06       Impact factor: 3.982

9.  Outcomes of adult-to-adult living donor liver transplantation: a single institution's experience with 335 consecutive cases.

Authors:  Daisuke Morioka; Hiroto Egawa; Mureo Kasahara; Takashi Ito; Hironori Haga; Yasutsugu Takada; Hiroshi Shimada; Koichi Tanaka
Journal:  Ann Surg       Date:  2007-02       Impact factor: 12.969

10.  Vascular reconstruction and complications in living donor liver transplantation in infants weighing less than 6 kilograms: the Kyoto experience.

Authors:  Yasumasa Shirouzu; Mureo Kasahara; Daisuke Morioka; Seisuke Sakamoto; Kaoru Taira; Kenji Uryuhara; Kohei Ogawa; Yasutsugu Takada; Hiroto Egawa; Koichi Tanaka
Journal:  Liver Transpl       Date:  2006-08       Impact factor: 5.799

View more
  17 in total

1.  Impact of the preoperative des-gamma-carboxy prothrombin level on prognosis after hepatectomy for hepatocellular carcinoma meeting the Milan criteria.

Authors:  Takanori Sakaguchi; Shohachi Suzuki; Yoshifumi Morita; Kousuke Oishi; Atsushi Suzuki; Kazuhiko Fukumoto; Keisuke Inaba; Satoshi Nakamura; Hiroyuki Konno
Journal:  Surg Today       Date:  2010-06-26       Impact factor: 2.549

2.  Current status of and prospects for the English medical journal Surgery Today.

Authors:  Yoshihiko Maehara; Yoshihiro Kakeji
Journal:  Surg Today       Date:  2010-12       Impact factor: 2.549

3.  A combination procedure with thrombolytic therapy and balloon dilatation for portal vein thrombus enables the successful performance of antiviral therapy after a living-donor liver transplantation: report of a case.

Authors:  Koji Hamasaki; Susumu Eguchi; Mitsuhisa Takatsuki; Kensuke Miyazaki; Akihiko Soyama; Masaaki Hidaka; Kosho Yamanouchi; Yoshitsugu Tajima; Takashi Kanematsu
Journal:  Surg Today       Date:  2010-09-25       Impact factor: 2.549

4.  How to handle a huge portosystemic shunt in adult living donor liver transplantation with a small-for-size graft: report of a case.

Authors:  Yasumasa Shirouzu; Yuki Ohya; Yukika Tsukamoto; Hidekazu Yamamoto; Kwang-Jong Lee; Hideaki Okajima; Katsuhiro Asonuma; Yukihiro Inomata
Journal:  Surg Today       Date:  2009-06-28       Impact factor: 2.549

5.  The expression of transporter OATP2/OATP8 decreases in undetectable hepatocellular carcinoma by Gd-EOB-MRI in the explanted cirrhotic liver.

Authors:  Masaaki Hidaka; Mitsuhisa Takatsuki; Sadayuki Okudaira; Akihiko Soyama; Izumi Muraoka; Takayuki Tanaka; Izumi Yamaguchi; Takanobu Hara; Hisamitsu Miyaaki; Tatsuki Ichikawa; Tomayoshi Hayashi; Ichiro Sakamoto; Kazuhiko Nakao; Tamotsu Kuroki; Takashi Kanematsu; Susumu Eguchi
Journal:  Hepatol Int       Date:  2012-06-24       Impact factor: 6.047

6.  Acute biliary obstruction due to a large intracholedochal hematoma after living-donor liver transplantation: Report of a case.

Authors:  Shigeyuki Nagata; Toru Ikegami; Kazuki Takeishi; Takeo Toshima; Keishi Sugimachi; Tomonobu Gion; Yuji Soejima; Akinobu Taketomi; Yoshihiko Maehara
Journal:  Surg Today       Date:  2010-04-28       Impact factor: 2.549

7.  Reversal of severe hepatopulmonary syndrome in chronic hepatic cirrhosis by living donor liver transplantation: report of two cases.

Authors:  Kefei Chen; Bo Li
Journal:  Surg Today       Date:  2011-03-02       Impact factor: 2.549

8.  Lack of grafted liver rejuvenation in adult-to-pediatric liver transplantation.

Authors:  Susumu Eguchi; Mitsuhisa Takatsuki; Masaaki Hidaka; Akihiko Soyama; Izumi Muraoka; Tetsuo Tomonaga; Isao Shimokawa; Takashi Kanematsu
Journal:  Dig Dis Sci       Date:  2010-10-09       Impact factor: 3.199

9.  Model for end-stage liver disease versus the Child-Pugh score in predicting the post-transplant 3-month and 1-year mortality in a cohort of Chinese recipients.

Authors:  Zhiyong Guo; Xiaoshun He; Linwei Wu; Weiqiang Ju; Anbin Hu; Qiang Tai; Dongping Wang; Yi Ma; Guodong Wang; Xiaofeng Zhu; Jiefu Huang
Journal:  Surg Today       Date:  2009-12-29       Impact factor: 2.549

10.  Outcomes of patients with benign liver diseases undergoing living donor versus deceased donor liver transplantation.

Authors:  Chuan Li; Kai Mi; Tian fu Wen; Lu nan Yan; Bo Li; Jia ying Yang; Ming qing Xu; Wen tao Wang; Yong gang Wei
Journal:  PLoS One       Date:  2011-11-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.